ÎÛÎÛ²ÝÝ®ÊÓƵ

News

Novel treatment of acute and chronic pain

Published: 26 March 2004
Antalium Inc. and Neuroceptor Inc., two spin-off companies of ÎÛÎÛ²ÝÝ®ÊÓƵ and Queen's Universities respectively, have merged to form a new leading-edge biopharmaceutical company called PainCeptor Pharma Corporation. The new company is focused on the development of novel and effective therapeutic drugs for the treatment of acute and chronic pain.
Back to top